| Year | Type | Det | Age | M/F | Prob | INC | NAP | Outc | NCA |
---|
White8
| 2005 | PC | 16 | 51 | 1.03 | All** | 69 | 0 | CLIN | - |
Gallagher9
| 2006 | PC | 64 | 49 | 0.53 | Low | 96 | 0.07 | CLIN | 5 |
Hoffmann10
| 2006 | PC | 16/64 | 57 | 0.53 | All** | 40 | 0 | CLIN | - |
Hoffmann11
| 2006 | PC | 64 | 54 | 0.58 | All** | 106 | 0.03 | CLIN | 8 |
Olivetti12
| 2006 | PC | 16 | 59 | 0.61 | U | 31 | 0 | CA | 31 |
Sato13
| 2006 | PC | 4/16 | 60 | 0.85 | U | 34 | 0.09 | CLIN | - |
Goldstein14
| 2007 | RCT | 64 | 48 | 0.43 | Low | 99 | 0.11 | CLIN | 12 |
Meijboom15
| 2007 | PC | 64 | 59 | 0,76 | Low | 33 | 0 | CA | 33* |
Rubinshtein16
| 2007 | PC | 64 | 56 | 1.76 | Int | 58 | 0 | CLIN | 17 |
- Type: Study type.
- RCT: Randomized controlled trial.
- PC: Prospective cohort.
- Det: Number of detectors.
- M/F: Male/Female ratio.
- Prob: Pre-test probability.
- INC: Number of included patients.
- NAP: Non assessable proportion of patients = Ratio of non-diagnostic versus included patients.
- Outc: reference standard used.
- NCA: Number of patients that underwent Conventional Angiography.
- Clin: Clinical.
- U: Unknown.
- *:only a fraction of the patients were included: the patients that clearly had negative biomarkers and were categorized as "low risk" in this study.
- **: included patients with pre-test probability ranging from low to high